Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Can we predict tuberculosis cure? What tools are available?
Delia Goletti, Cecilia S. Lindestam Arlehamn, Thomas J. Scriba, et al.
European Respiratory Journal (2018) Vol. 52, Iss. 5, pp. 1801089-1801089
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Epidemic and pandemic viral infections: impact on tuberculosis and the lung
Ong C, Giovanni Battista Migliori, Mario Raviǵlione, et al.
European Respiratory Journal (2020) Vol. 56, Iss. 4, pp. 2001727-2001727
Open Access | Times Cited: 126
Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2
Linda Petrone, Elisa Petruccioli, Valentina Vanini, et al.
International Journal of Infectious Diseases (2021) Vol. 113, pp. S82-S87
Open Access | Times Cited: 90
QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis
Giovanni Sotgiu, Laura Saderi, Elisa Petruccioli, et al.
Journal of Infection (2019) Vol. 79, Iss. 5, pp. 444-453
Closed Access | Times Cited: 83
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies
Jan Heyckendorf, Sophia B. Georghiou, Nicole Frahm, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 53
Clinical utilization of artificial intelligence in predicting therapeutic efficacy in pulmonary tuberculosis
Fuzhen Zhang, Fan Zhang, Liang Li, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 4, pp. 632-641
Open Access | Times Cited: 9
Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis Molecular Bacterial Load Assay
Wilber Sabiiti, Khalide Azam, Eoghan C. W. Farmer, et al.
Thorax (2020) Vol. 75, Iss. 7, pp. 606-608
Open Access | Times Cited: 68
Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients
Alessandra Aiello, Saeid Najafi Fard, Elisa Petruccioli, et al.
International Journal of Infectious Diseases (2021) Vol. 106, pp. 338-347
Open Access | Times Cited: 52
Biomarkers That Correlate with Active Pulmonary Tuberculosis Treatment Response: a Systematic Review and Meta-analysis
Alexandra J. Zimmer, Federica Lainati, Nathaly Aguilera Vasquez, et al.
Journal of Clinical Microbiology (2021) Vol. 60, Iss. 2
Open Access | Times Cited: 43
Disease extent and anti‐tubercular treatment response correlates with Mycobacterium tuberculosis‐specific CD4 T‐cell phenotype regardless of HIV‐1 status
Catherine Riou, Elsa Du Bruyn, Sheena Ruzive, et al.
Clinical & Translational Immunology (2020) Vol. 9, Iss. 9
Open Access | Times Cited: 44
Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection
Elisa Petruccioli, Teresa Chiacchio, Assunta Navarra, et al.
Journal of Infection (2020) Vol. 80, Iss. 5, pp. 536-546
Open Access | Times Cited: 43
Tools to implement the World Health Organization End TB Strategy: Addressing common challenges in high and low endemic countries
Seif Al Abri, Tereza Kasaeva, Giovanni Battista Migliori, et al.
International Journal of Infectious Diseases (2020) Vol. 92, pp. S60-S68
Open Access | Times Cited: 41
Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations
Hanif Esmail, Frank Cobelens, Delia Goletti
European Respiratory Journal (2020) Vol. 55, Iss. 3, pp. 1901957-1901957
Open Access | Times Cited: 40
Antibody Subclass and Glycosylation Shift Following Effective TB Treatment
Patricia S. Grace, Sepideh Dolatshahi, Lenette L. Lu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 35
Biomarkers of iron metabolism facilitate clinical diagnosis in Mycobacterium tuberculosis infection
Youchao Dai, Wanshui Shan, Qianting Yang, et al.
Thorax (2019) Vol. 74, Iss. 12, pp. 1161-1167
Open Access | Times Cited: 39
Association of baseline white blood cell counts with tuberculosis treatment outcome: a prospective multicentered cohort study
Carole Chedid, Eka Kokhreidze, Nestani Tukvadze, et al.
International Journal of Infectious Diseases (2020) Vol. 100, pp. 199-206
Open Access | Times Cited: 39
Plasma Chemokines Are Baseline Predictors of Unfavorable Treatment Outcomes in Pulmonary Tuberculosis
Nathella Pavan Kumar, Kadar Moideen, Arul Nancy, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 9, pp. e3419-e3427
Open Access | Times Cited: 34
Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoring
Rim Bayaa, Mame Diarra Ndiaye, Carole Chedid, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 29
Clinics of ocular tuberculosis: A review
Bjorn Kaijun Betzler, Vishali Gupta, Rupesh Agrawal
Clinical and Experimental Ophthalmology (2021) Vol. 49, Iss. 2, pp. 146-160
Closed Access | Times Cited: 28
Are mRNA based transcriptomic signatures ready for diagnosing tuberculosis in the clinic? - A review of evidence and the technological landscape
Yohhei Hamada, Adam Penn‐Nicholson, Sriram Krishnan, et al.
EBioMedicine (2022) Vol. 82, pp. 104174-104174
Open Access | Times Cited: 22
New Insights into Biomarkers for Evaluating Therapy Efficacy in Pulmonary Tuberculosis: A Narrative Review
Fuzhen Zhang, Fan Zhang, Yu Dong, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 12, pp. 2665-2689
Open Access | Times Cited: 11
Characterizing PET CT patterns and bacterial dissemination features of tuberculosis relapse in the macaque model
Pauline Maiello, Collin R. Diedrich, Tara Rutledge, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Relevance of QuantiFERON-TB Gold Plus and Heparin-Binding Hemagglutinin Interferon-γ Release Assays for Monitoring of Pulmonary Tuberculosis Clearance: A Multicentered Study
Carole Chedid, Eka Kokhreidze, Nestani Tukvadze, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 24
Evaluation of T cell responses with the QuantiFERON SARS-CoV-2 assay in individuals with 3 doses of BNT162b2 vaccine, SARS-CoV-2 infection, or hybrid immunity
Maria-Myrto Dourdouna, Elizabeth‐Barbara Tatsi, Vasiliki Syriopoulou, et al.
Diagnostic Microbiology and Infectious Disease (2023) Vol. 106, Iss. 3, pp. 115948-115948
Open Access | Times Cited: 10
Tuberculosis treatment monitoring tests during routine practice: study design guidance
Emily MacLean, Alexandra J. Zimmer, Saskia den Boon, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 4, pp. 481-488
Open Access | Times Cited: 3
Decreased IL-1 β Secretion as a Potential Predictor of Tuberculosis Recurrence in Individuals Diagnosed with HIV
Marina Nosik, Konstantin Ryzhov, А.V. Kudryavtseva, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 954-954
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top